GGrantScoutHQCreate alert

Industry funding

Health & Biomedical grants — Page 4

Public health, clinical, biomedical, behavioral health and care-delivery funding. Results combine structured categories with topic evidence from the listing and may overlap with related industries.

580 current opportunities · showing 73–96

OPENHealth & Medical

OJJDP FY 2026 Family Treatment Court Program

Office of Juvenile Justice Delinquency Prevention

This is a notice of funding opportunity (NOFO) for the OJJDP FY 2026 Family Treatment Court Program. This opportunity will support state and local courts, units of local government, and federally recognized Tribal governments to establish new, or enhance existing, family treatment courts to ensure t

Deadline
Nov 17, 2026
Funding
Estimated total program funding: $9,020,000
Check fit and official source →
OPENResearch & Science

DoW Joint Warfighter Medical, Military Medical Research and Development Award

Defense Health Agency Contracting Activity - DHACA

Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fund the logical continuation of previous Department of War (DOW)-funded research and development efforts relevant to the FY26 JWMRP

Deadline
Nov 17, 2026
Funding
Estimated total program funding: $8,800,000
Check fit and official source →
OPENResearch & Science

National Science Foundation Translation to Practice (NSF TTP)

U.S. National Science Foundation

The U.S. NSF Directorate for Technology, Innovation and Partnerships (NSF TIP) partners across sectors to advance three primary focus areas – accelerating technology translation and development, fostering regional innovation and economic growth, and preparing the American workforce for future

Deadline
Nov 18, 2026
Funding
Estimated total program funding: $30,000,000
Check fit and official source →
OPENHealth & Medical

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to el

Deadline
Nov 18, 2026
Funding
Estimated total program funding: $200,000
Check fit and official source →
OPENHealth & Medical

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this NOFO is to support research that advances (1) prevention approaches to reduce prenatal alcohol exposure and the incidenc

Deadline
Nov 18, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated fully remotely delivered and conducted clinical trials to assess the efficacy or effectiveness of complementary and integrative health interventions in NCCIH- designated areas of high research priority. Appl

Deadline
Nov 18, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)

National Institutes of Health

The goal of this notice of funding opportunity (NOFO) is to support feasibility trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) for conditions that have been identified by NCCIH as high-priorit

Deadline
Nov 18, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)

National Institutes of Health

This notice of funding opportunity (NOFO) invites applications for investigator-initiated clinical trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) in NCCIH-designated areas of high research pri

Deadline
Nov 18, 2026
Funding
Up to $350,000
Check fit and official source →
OPENHealth & Medical

2026 Local Partnership Competitive Program

Transportation Commission

The primary objective of this program is to provide funding to counties, cities, districts, and regional transportation agencies in which voters have approved fees or taxes dedicated solely to transportation improvements or that have imposed fees, including uniform developer fees, dedicated solely to transportation imp

Deadline
Nov 19, 2026
Funding
Dependant on number of submissions received, application process, etc.; $151,298,000.00
Check fit and official source →
OPENResearch & Science

Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)

National Institutes of Health

The purpose of this NOFO is to invite Research Project (R01) applications that propose to study the ethical, legal, and social implications (ELSI) of human genetics and genomics. Applications may propose studies using either single or mixed methods. Approaches may include but are not limited to empi

Deadline
Nov 19, 2026
Funding
See official notice
Check fit and official source →
OPENResearch & Science

DoW Orthopaedic, Clinical Research Award

Defense Health Agency Contracting Activity - DHACA

Summary: The fiscal year 2026 (FY26) Orthopaedic Research Program (ORP) Clinical Research Award (CRA) seeks clinical research that evaluates orthopaedic-specific factors and interventions. The ORP intends for research supported by this mechanism to generate clinically useful evidence with potential

Deadline
Nov 19, 2026
Funding
Estimated total program funding: $13,600,000
Check fit and official source →
OPENHealth & Medical

DoW Breast Cancer, Clinical Research Extension Award

Defense Health Agency Contracting Activity - DHACA

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact

Deadline
Nov 19, 2026
Funding
Estimated total program funding: $8,400,000
Check fit and official source →
OPENResearch & Science

DOW Combat Readiness – Medical Research Program Translational Research Award

Defense Health Agency Contracting Activity - DHACA

Summary: The fiscal year 2026 (FY26) Combat Readiness – Medical Research Program (CRRP) Translational Research Award (TRA) supports hypothesis-driven innovative, high-impact translational research that will accelerate the movement of promising ideas and/or technologies in trauma care into solu

Deadline
Nov 19, 2026
Funding
Estimated total program funding: $4,370,000
Check fit and official source →
OPENHealth & Medical

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

Defense Health Agency Contracting Activity - DHACA

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide ade

Deadline
Nov 19, 2026
Funding
Estimated total program funding: $10,600,000
Check fit and official source →
OPENResearch & Science

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)

National Institutes of Health

The purpose of this NOFO is to invite Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal, and social implications (ELSI) of human genetics and genomics. Applications may propose studies using either single or mixed methods. Approaches may include but

Deadline
Nov 19, 2026
Funding
See official notice
Check fit and official source →
OPENResearch & Science

DoW Orthopaedic, Applied Research Award

Defense Health Agency Contracting Activity - DHACA

Summary: The Orthopaedic Research Program (ORP) Applied Research Award (ARA) seeks applied research applications focused on advancing optimal treatment and restoration of function for individuals with orthopaedic injuries sustained during combat or service-related activities. Distinctive Features: &#

Deadline
Nov 19, 2026
Funding
Estimated total program funding: $3,800,000
Check fit and official source →
OPENResearch & Science

DoW Rare Cancers Idea Development Award

Defense Health Agency Contracting Activity - DHACA

Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation. Distinctive Features:The RCRP encourages applicants to in

Deadline
Nov 19, 2026
Funding
Estimated total program funding: $7,350,000
Check fit and official source →
OPENResearch & Science

DoW Rare Cancers Resource and Community Development Award

Defense Health Agency Contracting Activity - DHACA

Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Resource and Community Development Award (RCDA) supports the development of research resources and clinical or preclinical datasets that will advance the field of rare cancers research and ultimately improve outcomes for indiv

Deadline
Nov 19, 2026
Funding
Estimated total program funding: $5,600,000
Check fit and official source →
OPENHealth & Medical

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)

National Institutes of Health

This NOFO encourages applications for multi-site exploratory and confirmatory clinical trials focused on promising interventions; biomarker or outcome measure validation studies that are immediately preparatory to trials in stroke prevention, treatment, and recovery; and ancillary studies designed t

Deadline
Nov 20, 2026
Funding
See official notice
Check fit and official source →
OPENResearch & Science

DoW Toxic Exposures Investigator Initiated Research Award

Defense Health Agency Contracting Activity - DHACA

Summary: The fiscal year 2026 Toxic Exposures Research Program (TERP) Investigator-Initiated Research Award (IIRA) is intended to support studies that will make an important contribution toward research and/or patient care for diseases or conditions associated with military-related toxic exposures.

Deadline
Nov 20, 2026
Funding
Estimated total program funding: $2,400,000
Check fit and official source →
OPENResearch & Science

DoW Toxic Exposures Translational Research Award

Defense Health Agency Contracting Activity - DHACA

Summary: The intent of the fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Translational Research Award (TRA) is to support translational research that will accelerate the movement of promising ideas in military-related toxic exposure research into clinical applications, including he

Deadline
Nov 20, 2026
Funding
Estimated total program funding: $6,000,000
Check fit and official source →
OPENHealth & Medical

DoW Toxic Exposures Clinical Trial Award

Defense Health Agency Contracting Activity - DHACA

Summary: The fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases or

Deadline
Nov 20, 2026
Funding
Estimated total program funding: $4,500,000
Check fit and official source →
OPENHealth & Medical

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications that bundle independent protocols for phase 1 clinical trials with phase 1b/phase 2a clinical trials to streamline the early-stage evaluation of promising pharmacological interventions for Alzheimer's disease (AD

Deadline
Nov 20, 2026
Funding
See official notice
Check fit and official source →
OPENResearch & Science

Economic research on the returns to R&D investment (Grant)

UK Government

Word limit: 550 In plain English, provide a summary we can use to identify the most suitable experts to assess your application. We may make this summary publicly available on external-facing websites, therefore do not include any confidential or sensitive information. Make it suitable for a variety of readers, for exa

Deadline
Nov 20, 2026
Funding
See official notice
Check fit and official source →

Build a stronger shortlist

First confirm that your legal entity is an eligible applicant. Then check whether the proposed work, geography, award size and project period align with the current official notice. Industry relevance alone is not eligibility.